Pharmacological treatment of ADHD and comorbid SUD – improving treatment outcomes by combining research perspectives with clinical experience
Background International consensus statements and current research stress the importance of ADHD treatment in patients with concomitant SUD [1, 2], recommending multimodal, integrated treatment, including pharmacological and psychosocial interventions for both ADHD and SUD. ADHD medication in those with SUD is still controversial [1]. Both treatment access and treatment type vary widely across clinical sites. …